Health
BioNTech/Pfizer vaccine found effective against Covid-19 variant – Financial Times
Laboratory-based study shows mutations were neutralised by antibodies in blood of vaccinated patients
The Covid-19 vaccine developed by BioNTech and Pfizer is likely to be effective against a rapidly spreading strain of the virus that was first discovered in the UK, a laboratory-based study by the companies has shown.
The variant, known as B.1.1.7, has a high number of mutations, which has led to concerns that could bypass the immune defences built up by vaccines being rolled out worldwide, a large proportion of which have been made by BioNTech and Pfizer.
However, researchers at BioNTech’s headquarters…
-
Noosa News15 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General14 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News23 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family
-
General21 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965